Evidence map›Paper›PMID 23484909›Full record

ArticleBiochemistry2013

Inhibition of DD-peptidases by a specific trifluoroketone: crystal structure of a complex with the Actinomadura R39 DD-peptidase.

Liudmila Dzhekieva, S A Adediran, Raphael Herman, Frédéric Kerff, Colette Duez, Paulette Charlier, Eric Sauvage, R F Pratt

Abstract read
In one paragraph

Article in Biochemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Transient Formation of Hemiketals from Pentafluoro-Journal of fluorine chemistry · 2023
    Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Liudmila DzhekievaDepartment of Chemistry, Wesleyan University , Lawn Avenue, Middletown, Connecticut 06459, United States.
S A Adediran
Raphael Herman
Frédéric Kerff
Colette Duez
Paulette Charlier
Eric Sauvage
R F Pratt

Funding

BETA LACTAMASES AND DD PEPTIDASES--ACTIVE SITE CHEMISTRYR01AI017986 · NIAID · WESLEYAN UNIVERSITY · PI PRATT, REX F · 1985 to 2010
$3.0M
Beta-Lactamases and DD-Peptidases: Active Site ChemistryR56AI017986 · NIAID · WESLEYAN UNIVERSITY · PI PRATT, REX F · 2008 to 2008
$413k
NIAID NIH HHS AI-17986NIAID NIH HHS R01 AI017986NIAID NIH HHS R56 AI017986
6 · The paper itself

Abstract

Inhibitors of bacterial DD-peptidases represent potential antibiotics. In the search for alternatives to β-lactams, we have investigated a series of compounds designed to generate transition state analogue structures upon reaction with DD-peptidases. The compounds contain a combination of a peptidoglycan-mimetic specificity handle and a warhead capable of delivering a tetrahedral anion to the enzyme active site. The latter includes a boronic acid, two alcohols, an aldehyde, and a trifluoroketone. The compounds were tested against two low-molecular mass class C DD-peptidases. As expected from previous observations, the boronic acid was a potent inhibitor, but rather unexpectedly from precedent, the trifluoroketone [D-α-aminopimelyl(1,1,1-trifluoro-3-amino)butan-2-one] was also very effective. Taking into account competing hydration, we found the trifluoroketone was the strongest inhibitor of the Actinomadura R39 DD-peptidase, with a subnanomolar (free ketone) inhibition constant. A crystal structure of the complex between the trifluoroketone and the R39 enzyme showed that a tetrahedral adduct had indeed formed with the active site serine nucleophile. The trifluoroketone moiety, therefore, should be considered along with boronic acids and phosphonates as a warhead that can be incorporated into new and effective DD-peptidase inhibitors and therefore, perhaps, antibiotics.

Indexed as

ActinomycetalesAnti-Bacterial AgentsBacterial Proteinsbeta-LactamsButanonesCatalytic DomainCrystallography, X-RayDrug DesignDrug Evaluation, PreclinicalModels, MolecularProtease InhibitorsSerine-Type D-Ala-D-Ala CarboxypeptidaseAnti-Bacterial AgentsBacterial Proteinsbeta-LactamsButanonesProtease InhibitorsSerine-Type D-Ala-D-Ala Carboxypeptidase

Identifiers

PMID23484909
PMCPMC3731424

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.